{"nct_id":"NCT05669014","title":"A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2023-12-04","start_date_type":"ACTUAL","primary_completion_date":"2025-07-02","primary_completion_date_type":"ACTUAL","completion_date":"2025-07-02","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AMGN"]}